Theradiag (France) Price on September 23, 2024
| ALTHE Stock | EUR 0.37 0.03 8.82% |
If you're considering investing in Theradiag Stock, it is important to understand the factors that can impact its price. As of today, the current price of Theradiag stands at 0.37, as last reported on the 25th of November, with the highest price reaching 0.37 and the lowest price hitting 0.36 during the day. Theradiag appears to be out of control, given 3 months investment horizon. Theradiag SA owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0932, which indicates the firm had a 0.0932% return per unit of risk over the last 3 months. We have found thirty technical indicators for Theradiag SA, which you can use to evaluate the volatility of the company. Please review Theradiag's Risk Adjusted Performance of 0.0792, coefficient of variation of 1080.76, and Semi Deviation of 2.63 to confirm if our risk estimates are consistent with your expectations.
Theradiag Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Theradiag |
Sharpe Ratio = 0.0932
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ALTHE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.47 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.42 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Theradiag is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theradiag by adding it to a well-diversified portfolio.
Theradiag Valuation on September 23, 2024
It is possible to determine the worth of Theradiag on a given historical date. On September 23, 2024 Theradiag was worth 0.39 at the beginning of the trading date compared to the closed value of 0.38. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Theradiag stock. Still, in general, we apply an absolute valuation method to find Theradiag's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Theradiag where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Theradiag's related companies.
| Open | High | Low | Close | Volume | |
| 0.40 | 0.40 | 0.38 | 0.39 | 25,824 | |
09/23/2024 | 0.39 | 0.39 | 0.38 | 0.38 | 6,671 |
| 0.38 | 0.39 | 0.38 | 0.39 | 691.00 |
| Backtest Theradiag | | | Theradiag History | | | Theradiag Valuation | Previous | Next |
Theradiag Trading Date Momentum on September 23, 2024
| On September 24 2024 Theradiag SA was traded for 0.39 at the closing time. The highest price during the trading period was 0.39 and the lowest recorded bid was listed for 0.38 . The volume for the day was 691. This history from September 24, 2024 contributed to the next trading day price gain. The overall trading delta to the next closing price was 2.63% . The trading price change to the current price is 10.53% . |
Theradiag SA Fundamentals Correlations and Trends
By evaluating Theradiag's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Theradiag's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Theradiag financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Theradiag Stock history
Theradiag investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Theradiag is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Theradiag SA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Theradiag stock prices may prove useful in developing a viable investing in Theradiag
Theraclion SA develops, manufactures, and markets Echopulse ultrasound medical imaging tool for the non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules to practitioners. The company was founded in 2004 and is based in Malakoff, France. THERACLION operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 22 people.
Theradiag Stock Technical Analysis
Theradiag technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Theradiag Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Theradiag SA cannot be verified against its exchange. Please verify the symbol is currently traded on Euronext Paris. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Theradiag November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Theradiag stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Theradiag shares will generate the highest return on investment. By undertsting and applying Theradiag stock market strength indicators, traders can identify Theradiag SA entry and exit signals to maximize returns
Theradiag Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Theradiag's price direction in advance. Along with the technical and fundamental analysis of Theradiag Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Theradiag to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0792 | |||
| Jensen Alpha | 0.409 | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | 0.0658 | |||
| Treynor Ratio | (5.92) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Theradiag Stock Analysis
When running Theradiag's price analysis, check to measure Theradiag's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theradiag is operating at the current time. Most of Theradiag's value examination focuses on studying past and present price action to predict the probability of Theradiag's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theradiag's price. Additionally, you may evaluate how the addition of Theradiag to your portfolios can decrease your overall portfolio volatility.